Reduced year-over-year operating expenses by $4.7 million and posted lowest operating loss as a public company in the second quarter of 2025 Generated positive net cash provided by operating activities of $4.6 million in the second quarter of 2025 LOS ANGELES, Aug. 13, 2025 (GLOBE NEWSWIRE) — Xos, Inc. (NASDAQ: XOS) (“Xos” or the “Company”),… Continue reading @niche: Xos Hits New Milestones in Q2 2025 with Highest Revenue and Deliveries in the Company’s History004005
Tag: Financial Results
Vitamin B12 Market Set to Surpass USD 444.47 Million by 2030, Driven by Rising Veganism, Preventive Healthcare Focus, and Growth in Nutraceuticals: MarkNtel Advisors
NEW DELHI, Aug. 14, 2025 /PRNewswire/ — The Global Vitamin B12 Market is on track to grow from USD 288 million in 2024 to USD 444.47 million by 2030, representing a compound annual growth rate (CAGR) of 7.50%, according to the latest industry research. The market’s expansion is being fueled by heightened consumer awareness of Vitamin… Continue reading Vitamin B12 Market Set to Surpass USD 444.47 Million by 2030, Driven by Rising Veganism, Preventive Healthcare Focus, and Growth in Nutraceuticals: MarkNtel Advisors
Minesto publishes Half-Year Report 2025
GOTHENBURG, Sweden, Aug. 14, 2025 /PRNewswire/ — CEO Dr Martin Edlund: “As the leading pioneer in Ocean Renewable Energy, Minesto moves on with more determination and positive spirit than ever to deliver renewable tidal energy to the world” Significant events April-June 2025 During second quarter, Minesto continued operation and testing activities in Vestmanna, Faroe Islands. Since beginning of May, the… Continue reading Minesto publishes Half-Year Report 2025
Minesto publishes Half-Year Report 2025
GOTHENBURG, Sweden, Aug. 14, 2025 /PRNewswire/ — CEO Dr Martin Edlund: “As the leading pioneer in Ocean Renewable Energy, Minesto moves on with more determination and positive spirit than ever to deliver renewable tidal energy to the world” Significant events April-June 2025 During second quarter, Minesto continued operation and testing activities in Vestmanna, Faroe Islands. Since beginning of May, the… Continue reading Minesto publishes Half-Year Report 2025
LOR Continues Modest Declines In Q2
Body shops can get jobs done on rental cars brought in more quickly. Go to Source
TORM plc Q2 2025 Results, Dividend Distribution, and Financial Outlook 2025
HELLERUP, Denmark, Aug. 14, 2025 /PRNewswire/ — INSIDE INFORMATION “TORM delivered a strong second-quarter result with continued market-leading performance, against a backdrop of global uncertainty,” says Jacob Meldgaard, adding: “We see strong momentum heading into the second half of the year, and as a result, we are raising our full-year guidance.” Financial Results In the second… Continue reading TORM plc Q2 2025 Results, Dividend Distribution, and Financial Outlook 2025
Implantica publishes Interim Report January – June 2025 (Q2)
VADUZ, Liechtenstein, Aug. 14, 2025 /PRNewswire/ — Transforming Clinical Excellence of RefluxStop® into Strategic Market Momentum Significant events in the second quarter of 2025 FDA PMA Submission Completed – Submitted third and final module of the U.S. FDA pre-market approval (PMA) application for RefluxStop®, including responses to questions on the second module; Feedback on module 3… Continue reading Implantica publishes Interim Report January – June 2025 (Q2)
NORDEN reports net profit of USD 52 million (DKK 342 million) in Q2 2025
ANNOUNCEMENT NO. 163 – 14 AUGUST 2025 HELLERUP, Denmark, Aug. 14, 2025 /PRNewswire/ — Despite challenging market conditions, NORDEN delivered a net profit of USD 52 million (DKK 342 million) in the second quarter of 2025 and a return on invested capital of 10% LTM. In H1 2025, the net profit was USD 85 million,… Continue reading NORDEN reports net profit of USD 52 million (DKK 342 million) in Q2 2025
NORDEN reports net profit of USD 52 million (DKK 342 million) in Q2 2025
ANNOUNCEMENT NO. 163 – 14 AUGUST 2025 HELLERUP, Denmark, Aug. 14, 2025 /PRNewswire/ — Despite challenging market conditions, NORDEN delivered a net profit of USD 52 million (DKK 342 million) in the second quarter of 2025 and a return on invested capital of 10% LTM. In H1 2025, the net profit was USD 85 million,… Continue reading NORDEN reports net profit of USD 52 million (DKK 342 million) in Q2 2025
Navamedic ASA: Financial report for the 2nd quarter and first half of 2025
OSLO, Norway, Aug. 14, 2025 /PRNewswire/ — In the first half of 2025, Navamedic ASA (OSE: NAVA), a Nordic pharma company and trusted supplier of high-quality prescription, consumer health, and hospital products to hospitals and pharmacies, delivered revenues of NOK 269.3 million, down from NOK 277.2 million in 2024. Excluding the milestone license fee from Orion… Continue reading Navamedic ASA: Financial report for the 2nd quarter and first half of 2025